GARDASIL® Questions and Answers
Description
Publication Year: 2010
Language: English
Website: http://www.fda.gov/BiologicsBloodVaccines/Vaccines/QuestionsaboutVaccines/ucm096052.htm
This fact sheet answers questions about Gardasil, the first vaccine for the prevention of cervical cancer, abnormal and precancerous cervical lesions, abnormal and precancerous vaginal and vulvar lesions and genital warts. Gardasil is a recombinant vaccine and is effective against HPV types 6, 11, 16 and 18, and is approved for use in females ages 9-26 years.
Availability
This publication is available only on the Internet.
Source
U.S. Food and Drug Administration
10903 New Hampshire Ave.
Silver Spring MD 20993
Phone: (301) 796-8240 Emergency Operations
Toll-free Phone: (800) 332-4010 Food and Seafood Info.
Related topics:
Is this your organization's publication? Contact us if your information has changed.
womenshealth.gov
A federal government website managed by the Office on Women's Health in the Office of the Assistant Secretary for Health at the U.S. Department of Health and Human Services.
200 Independence Avenue, S.W. • Washington, DC 20201